A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis - Richard J. Nowak; Michael Benatar; Emma Ciafaloni; James F. Howard; M. Isabel Leite; Kimiaki Utsugisawa; John Vissing; Mikhail Rojavin; Qing Li; Fengming Tang; Yanping Wu; Nishi Rampal; et al. (New England Journal of Medicine, 2025)